GGrantScoutHQCreate alert

Curated topic

Community Grants for Local Governments — Page 2

Place-based opportunities listing county, city, township or special-district applicants.

249 current opportunities · showing 25–48

OPENHealth & Medical

Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated fully remotely delivered and conducted clinical trials to assess the efficacy or effectiveness of complementary and integrative health interventions in NCCIH- designated areas of high research priority. Appl

Deadline
Nov 18, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)

National Institutes of Health

The goal of this notice of funding opportunity (NOFO) is to support feasibility trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) for conditions that have been identified by NCCIH as high-priorit

Deadline
Nov 18, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)

National Institutes of Health

This notice of funding opportunity (NOFO) invites applications for investigator-initiated clinical trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) in NCCIH-designated areas of high research pri

Deadline
Nov 18, 2026
Funding
Up to $350,000
Check fit and official source →
OPENResearch & Science

Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)

National Institutes of Health

The purpose of this NOFO is to invite Research Project (R01) applications that propose to study the ethical, legal, and social implications (ELSI) of human genetics and genomics. Applications may propose studies using either single or mixed methods. Approaches may include but are not limited to empi

Deadline
Nov 19, 2026
Funding
See official notice
Check fit and official source →
OPENResearch & Science

Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)

National Institutes of Health

The purpose of this NOFO is to invite Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal, and social implications (ELSI) of human genetics and genomics. Applications may propose studies using either single or mixed methods. Approaches may include but

Deadline
Nov 19, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)

National Institutes of Health

This NOFO encourages applications for multi-site exploratory and confirmatory clinical trials focused on promising interventions; biomarker or outcome measure validation studies that are immediately preparatory to trials in stroke prevention, treatment, and recovery; and ancillary studies designed t

Deadline
Nov 20, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications that bundle independent protocols for phase 1 clinical trials with phase 1b/phase 2a clinical trials to streamline the early-stage evaluation of promising pharmacological interventions for Alzheimer's disease (AD

Deadline
Nov 20, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to support SenNet Discovery and Validation Centers (SenNet DVCs) as a core component of Stage 2 of the NIH Common Fund Cellular Senescence Network (SenNet). Building on Stage 1 resources, DVCs will define, refine, and validate tissue- and d

Deadline
Nov 24, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit the development of innovative senescence technologies (SenTecs), or the adaptation of existing technologies focused on identification, characterization and understanding the biological consequences of senescent cell (SnC) heterog

Deadline
Nov 24, 2026
Funding
Estimated total program funding: $6,000,000
Check fit and official source →
OPENHealth & Medical

Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to support the SenNet Data Coordination and Integration Center (SenNet DCIC) as a core component of Stage 2 of the NIH Common Fund Cellular Senescence Network (SenNet). The DCIC will enable timely, high-quality submission, harmonization, in

Deadline
Nov 24, 2026
Funding
Estimated total program funding: $3,000,000
Check fit and official source →
OPENHealth & Medical

Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)

National Institutes of Health

The National Institutes of Health (NIH) hereby notifies NIH award recipients that funds may be available for revision applications to support the expansion of existing projects and/or programs within the awarding IC identified in the competitive revision Notice of Special Interest (NOSI). Applicatio

Deadline
Nov 25, 2026
Funding
See official notice
Check fit and official source →
OPENClimate & Environment

F26AS00023 FY2026 Prescott Marine Mammal Rescue and Response Grant Program

Fish and Wildlife Service

The John H. Prescott Marine Mammal Rescue and Response Grant Program (Prescott program) provides financial assistance to eligible marine mammal stranding participants and stranding network collaborators to provide (A) the recovery, care, or treatment of sick, injured, or entangled marine mammals; (B

Deadline
Dec 1, 2026
Funding
Estimated total program funding: $2,350,000
Check fit and official source →
OPENHealth & Medical

NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)

National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to provide salary support for exceptional Research Software Engineers (RSEs) that contribute their skills to the development and dissemination of biomedical, behavioral or health related software, tools, and algorithms as well as to the tra

Deadline
Dec 5, 2026
Funding
See official notice
Check fit and official source →
OPENClimate & Environment

Great Lakes Restoration Initiative: Community Forest and Open Space Conservation Program

Forest Service

Federally recognized Indian Tribes, local government entities, and nonprofit organizations that are qualified to acquire and manage land may apply for up to $1,000,000 for the fee simple acquisition of private forest land in portions of the Lake Superior Basin of Michigan and Wisconsin. Projects sub

Deadline
Dec 9, 2026
Funding
Estimated total program funding: $3,500,000
Check fit and official source →
OPENEducation

National Parks Business Plan Internship

National Park Service

The National Parks Business Plan Internship (BPI) goal is to jointly administer a graduate-level internship program focused on improving the business management and operational health of our national parks and NPS programs. The internship program should:Provide students with in-depth training on NPS

Deadline
Jan 5, 2027
Funding
Estimated total program funding: $1,700,000
Check fit and official source →
OPENHealth & Medical

Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)

National Institutes of Health

The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICs) are issuing this R01 to solicit applications to address barriers and facilitators that impede use or uptake of cancer screening and preventive services in populations t

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate translation of scientific discoveries and engineering developments in imaging, data science and/or spectroscopic technologies into methods or tools that address contemporary problems in unders

Deadline
Jan 8, 2027
Funding
Estimated total program funding: $500,000
Check fit and official source →
OPENHealth & Medical

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) aims to support research on interdisciplinary population approaches to increasing awareness of the relationship between alcohol and cancer risk, understanding and changing social norms related to alcohol consumption, developing and/or evaluating alcohol poli

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

National Institutes of Health

Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research missi

Deadline
Jan 8, 2027
Funding
Estimated total program funding: $499,999
Check fit and official source →
OPENHealth & Medical

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

National Institutes of Health

Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials that have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception, he

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENEducation

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)

National Institutes of Health

The goal of this NOFO is to support R21 applications for novel theory and methods development that better delineate how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should be interdisciplinary across the natural and s

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

National Institutes of Health

The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists wh

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

National Institutes of Health

The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists wh

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →

Strong fit signals

  • The public need is documented
  • The jurisdiction can accept the award
  • Implementation ownership is clear

Requirements to verify

  • Population or geography thresholds
  • Maintenance and long-term operating costs

How to use this shortlist

Open the official notice for each candidate and build a simple go/no-go table covering legal applicant type, geography, project purpose, award range, match, registrations and submission time zone. Eliminate any program that fails a mandatory condition before spending time on narrative drafting.

Frequently asked questions

Who should use this community grants for local governments page?

Local governments and special districts. Treat the directory match as a discovery signal and confirm the controlling eligibility language on the funder's notice.

How are opportunities selected?

The page applies a fixed combination of structured applicant, focus, source, award or deadline signals to current directory records. It does not broaden the result with unrelated keywords.

Does a listing mean my organization is eligible?

No. A match helps build a shortlist; the official notice, application package and funder guidance control eligibility and allowable costs.